Flu vaccine production at Sanofi Pasteur
HTML-код
- Опубликовано: 8 сен 2024
- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2016-2017 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA) for shipment. This represents the first of more than 65 million total doses of seasonal influenza vaccine manufactured by Sanofi Pasteur that will be delivered to U.S. health care providers and pharmacies beginning in July and continuing throughout the remainder of the year. Sanofi Pasteur plans to increase its supply to respond to the shifting pediatric public health needs.
Seasonal influenza activity typically occurs between October and May and peaks between December and February. However, influenza activity peaked noticeably late last season occurring in early March 2016.1 Influenza seasons are always unpredictable as new influenza strains emerge and strain activity fluctuates throughout the year, making timely vaccination even more important to help protect against the virus, especially for seniors, young children and infants six months of age and older.
To view the multimedia release go to:
www.multivu.com...
You always show the very last step of packaging. We're not idiots (well maybe we are)
I wonder how they make a big batch of antigens for their production lines.
Interesting to see
Eggs.
Your here from 2020......Hi
@John Boss to be honest I don’t remember 😂😂😂😂 I’m having a Joe Biden moment
Eggs are what are used to grow the cultures, used in vaccines. Not baby fetuses. Proof right there